Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Ikena Oncology, Inc. (IKNA) had Normalized Pre-Tax Income of $-68.33M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$9.16M |
|
$-68.17M |
|
-- |
|
$9.16M |
|
$84.58M |
|
$-75.42M |
|
$7.09M |
|
$-68.33M |
|
|
Normalized Pre-Tax Income |
$-68.33M |
$-68.17M |
|
$-68.17M |
|
$-68.17M |
|
$-68.17M |
|
$-75.42M |
|
$-76.42M |
|
41.73M |
|
41.73M |
|
$-1.63 |
|
$-1.63 |
|
| Balance Sheet Financials | |
$178.66M |
|
$2.33M |
|
$13.43M |
|
$192.09M |
|
$14.21M |
|
-- |
|
$8.13M |
|
$22.34M |
|
$169.76M |
|
$169.76M |
|
$169.76M |
|
48.26M |
|
| Cash Flow Statement Financials | |
$-79.74M |
|
$64.14M |
|
$75.98M |
|
$60.79M |
|
$121.17M |
|
$60.38M |
|
$7.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-823.33% |
|
-823.33% |
|
-834.28% |
|
-745.94% |
|
-744.17% |
|
$-80.16M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-40.16% |
|
-40.16% |
|
-35.49% |
|
-40.16% |
|
$3.52 |
|
$-1.92 |
|
$-1.91 |
|